Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 November 2022 | Story Leonie Bolleurs | Photo Leonie Bolleurs
UFS green concrete
The Department of Engineering Sciences (EnSci) welcomes collaborations with other departments at the UFS. Pictured here are, from the left: Louis Lagrange, Head of EnSci, Prof Kahilu Kajimo-Shakantu, Head of the Department of Quantity Surveying and Construction Management, Dr Abdolhossein Naghizadeh, and Megan Welman-Purchase, analytical scientist in the Department of Geology.

More than 30 million tonnes of fly ash (residue from coal combustion in power plants) are generated in South Africa annually, with 96% of that being disposed of in landfills. There is thus more than enough of this key ingredient to produce green concrete. 

Green concrete, so called due to its environmentally friendly benefits, is an eco-friendly alternative to conventional concrete based on the Portland cement binder. During the production of green concrete, less carbon dioxide is released into the atmosphere than with the production of ordinary Portland cement (OPC). The latter accounts for up to 8% of all global carbon emissions.

Successful tests

In the Green Concrete Lab, established in 2021 within the Department of Engineering Sciences (EnSci) on the Bloemfontein Campus of the University of the Free State (UFS), Dr Abdolhossein Naghizadeh, Senior Lecturer, researcher, and engineer, is working on green cement and concrete projects.

He uses ‘geopolymer’ technology and a mix of waste materials, alkaline solutions, and recycled aggregates to form concrete mixtures that can provide properties similar to conventional concrete.

Besides being a synthesised inorganic material (not a petrochemical product), the geopolymer cement he introduced has the following properties: it is made from a reaction between aluminosilicate materials and strong alkalis (5-7% of the concrete mixture), it uses water and by-products as raw materials, it does not calcinate lime, thus giving it a low carbon emission, and it is also beneficial from a waste management point of view. 

The waste materials used can include waste from industrial and agricultural sources, such as fly ash, rice husk ash, sugar-cane bagasse, or corncob ash, as well as natural materials such as volcanic ash. In South Africa, sufficient amounts of industrial and agricultural waste are available. 

“So far, we have successfully tested various types of green concrete based on different waste materials,” says Dr Naghizadeh. 

Besides researching the green mixture proportions in the lab, Dr Naghizadeh and his students focused their attention on establishing the strength, durability, workability, and production cost of the product. 

They compared green concrete with conventional concrete. Green concrete’s workability is slightly lower (but he believes that with appropriate mix design it can be corrected), and it has a much higher compressive strength (50-90 MPa), a smaller carbon footprint, and comparable production costs to conventional concrete (depending on the mix design). A very high level of resistance against alkali-silica reaction (concrete cancer) is also present, as well as resistance to carbonation, sulphate attack, and acid attack.
So far, we have successfully tested various types of green concrete based on different waste materials.– Dr Naghizadeh. 

He explains, “The superior durability performance of green concrete is related to its chemical compositions and microstructure. For example, the lack of calcium content in the composition provides better resistance to alkali-silica reaction. At the same time, stronger bonds between elements and polymeric microstructure provide better resistance against acids and fire.”

With all the work and research of the past year and a half, Dr Naghizadeh says they are at the stage where they can prescribe green concrete production recipes for the industry parties based on the specified application and the materials they have.

Biggest accomplishments

“We transferred most of the experimental works to the Green Concrete Lab at the beginning of 2022, which improved our productivity tremendously. Since then, nine journal papers and three peer-reviewed conference papers have been published as outputs of the research projects. Currently, there are also multiple publications under review or in the development stages,” says Dr Naghizadeh.

In addition to him, there are three master's students and one research associate working on their own individual projects.

The department is very proud of its research outputs. Dr Naghizadeh was either author or co-author of all 12 research papers. The focus of these papers was mostly on the formulation of green concrete, based on locally available agricultural waste materials, the formulation of one-part geopolymer cement (when aluminosilicate raw material is replaced with pre-activated aluminosilicate material, water can be used instead of alkali solution), and the development of ambient-cured green concrete (replacing the aluminosilicate raw material with a blend of materials).

Dr Naghizadeh is also the project leader of a group of scientists from local and international universities who are researching sustainable construction materials. These institutions include the Universities of Johannesburg, KwaZulu-Natal, Yaoundé in Cameroon, Erzurum Technical University in Turkey, as well as Nelson Mandela University and the Central University of Technology, which recently came on board. 

 


 


News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors  Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept